Embed this press release by copying the code below:
NASDAQ: OBLN Investor Notice: Update in Lawsuit Against Obalon Therapeutics Inc
NASDAQ: OBLN Investor Notice: Update in Lawsuit Against Obalon Therapeutics Inc